NCT06824441Active, not recruiting
Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer
Symptom Reporting by Children, Adolescents and Young Adults With Cancer and Their Caregivers During a Clinic Visit: A Feasibility, Usability and Acceptability Study
Source: ClinicalTrials.gov · Last updated 12 Aug 2026
Brief summary (registry, in English)
The purpose of this project is to pilot test an electronically delivered symptom assessment tool Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE), completed by children/adolescents and young adults (AYAs) and caregivers and shared with their clinicians during an outpatient clinic visit, in preparation for a future test of intervention efficacy.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 85 (actual)
- First submitted
- 7 Feb 2025
- Start date
- 18 Aug 2024
- Primary completion date
- Oct 2026
- Lead sponsor
- Stanford University
- Diseases
- Childhood cancers
- NCT number
- NCT06824441
What you commit to
- Study type: Interventional
- Participants enrolled: 85
- From 18 Aug 2024 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1\. Child must not have cognitive/memory impairments determined by the child's clinician
Who the study is looking for
- First diagnosis of cancer
- Receiving cancer therapy: surgery, myelosuppressive chemotherapy and/or radiation 7-21 years of age
- Completed at least 1 month of cancer chemotherapy treatment and are within 7-28 days of starting a treatment cycle or during ongoing therapy, followed at least every month in clinic
- If surgery was part of treatment, the patient must be 3-6 weeks post surgery before participating in study
- Caregiver must be present and 18 years and older
- Ability to understand and the willingness to personally sign the written IRB-approved informed consent or assent document as appropriate
- Disease can be newly diagnosed, in relapse or refractory, as long as this is the first diagnosis of cancer
- Child must be able to read or listen to and understand English
Age in the registry: 7 years to 21 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University Coordinator of this site? Confirm its status | Palo Alto | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.